Business
‘Robust immune responses’: Oxford virus trial offers hope for elderly – The New Daily
Oxford University-AstraZeneca’s coronavirus vaccine has produced a robust immune response in elderly people, according to early test results.
The COVID-19 vaccine being developed by the University of Oxford produces an immune response in both elderly and young people and adverse reactions were lower among the elderly, British drug maker AstraZeneca says.
A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people, hammered the global economy and shuttered normal life across the world.
The Financial Times reported the vaccine, being developed by Oxford and AstraZeneca,…
-
Noosa News19 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General17 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
Noosa News21 hours agoWomen’s Softball World Cup 2027 Redcliffe Brisbane
-
General21 hours agoMan dies at shopping centre car park at Charlestown following reports of assault